ABIONYX Pharma S.A.
ABNX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€4,381 | -€3,518 | -€4,206 | -€5,822 |
| Dep. & Amort. | €0 | €153 | €135 | €119 |
| Deferred Tax | €0 | €0 | €0 | -€815 |
| Stock-Based Comp. | €0 | €20 | €506 | €815 |
| Change in WC | -€28 | €538 | €97 | -€1,744 |
| Other Non-Cash | €809 | -€891 | €109 | €755 |
| Operating Cash Flow | -€3,600 | -€3,698 | -€3,359 | -€6,692 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€76 | -€104 | -€175 | -€166 |
| Net Acquisitions | €0 | €0 | €0 | €1,504 |
| Inv. Purchases | €0 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €0 | €0 | €0 | €0 |
| Other Inv. Act. | -€24 | -€26 | €0 | €0 |
| Investing Cash Flow | -€100 | -€130 | -€175 | €1,338 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€490 | -€300 | -€236 | -€19 |
| Stock Issued | €3,358 | €4,186 | €42 | €4,056 |
| Stock Repurch. | -€24 | €0 | €0 | -€65 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€44 | €0 | €0 | €0 |
| Financing Cash Flow | €2,800 | €3,886 | -€194 | €3,972 |
| Forex Effect | -€3 | €0 | €0 | €0 |
| Net Chg. in Cash | -€902 | €58 | -€3,728 | -€1,382 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €4,102 | €4,044 | €7,772 | €9,154 |
| End Cash | €3,200 | €4,102 | €4,044 | €7,772 |
| Free Cash Flow | -€3,600 | -€3,828 | -€3,534 | -€6,858 |